Market Research Report
Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Pump & Patch), Diabetes Apps, Service, Data Management Software), Device Type (Hand-held & Wearables),End User - Global Forecast to 2024
|Published by||MarketsandMarkets||Product code||779341|
|Published||Content info||220 Pages
Delivery time: 1-2 business days
|Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Pump & Patch), Diabetes Apps, Service, Data Management Software), Device Type (Hand-held & Wearables),End User - Global Forecast to 2024|
|Published: January 24, 2019||Content info: 220 Pages||
"The Global Digital Diabetes Management Market is Projected to Grow at a CAGR of 23.8%."
The digital diabetes management market is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%. Factors such as the rising prevalence of diabetes, growing adoption of cloud-based enterprise solutions for diabetes management, increasing penetration of digital platforms and adoption of mobile apps for diabetes management, and technological advancements are driving the growth of the digital diabetes management market. However, high device costs and lack of reimbursement in developing countries and the higher acceptance of traditional diabetes management devices are expected to restrain market growth to a certain extent during the forecast period.
On the basis of product & service, the digital diabetes management market is segmented into devices, apps, data management software & platforms, and services. The apps segment is expected to register the highest CAGR during the forecast period. The high acceptance of mobile apps for remote monitoring is the major factor driving the growth of this market segment.
On the basis of end user, the digital diabetes management market is segmented into self/home healthcare, hospitals & specialty diabetes clinics, and academic & research institutes. The self/home healthcare segment is expected to witness the highest CAGR owing to the launch of advanced diabetes management devices for self/home care and the shift of diabetes management from clinical settings to home care, self-administration, and remote monitoring.
North America is expected to witness the highest CAGR during the forecast period, owing to the high adoption of connected diabetes management devices and apps, growing demand for technologically advanced solutions such as closed-loop systems, high adoption of remote online coaching services for diabetes management, favorable reimbursement policies, increased acceptance of digital diabetes solutions from payers, rising awareness on self-diabetes management, and government initiatives to promote digital health.
A breakdown of the primary participants referred to for this report is provided below:
Prominent players in the global digital diabetes management market are: Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel).
The report analyzes the market for various digital diabetes management products and their adoption pattern. It aims at estimating the market size and future growth potential of the global digital diabetes management market and different segments such as product & service, device type, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.